SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells
Open Access
- 26 October 2022
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (5) , e0160422
Abstract
Viruses generally learn to coexist with the host during the process of evolution. It is expected that SARS-CoV-2 would also evolve to coexist in humans by trading off its virulence for longer persistence, causing milder disease.Keywords
Funding Information
- Council of Scientific and Industrial Research, India (Fellowship)
- Department of Biotechnology, Ministry of Science and Technology, India (Fellowship)
- Department of Science and Technology, Ministry of Science and Technology, India (Fellowship)
- Council of Scientific and Industrial Research, India (6/1/FIRST/2020-RPPBDD-TMD-SeMI)
- Department of Science and Technology, Ministry of Science and Technology, India (IPA/2020/000070)
This publication has 41 references indexed in Scilit:
- On the origin and continuing evolution of SARS-CoV-2National Science Review, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotypeNature Biotechnology, 2019
- The phylogenomics of evolving virus virulenceNature Reviews Genetics, 2018
- Control of adaptive immunity by the innate immune systemNature Immunology, 2015
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresBioinformatics, 2013
- Cutadapt removes adapter sequences from high-throughput sequencing readsEMBnet.Journal, 2011
- Evolution of virulenceInfectious Disease Clinics of North America, 2004